Our news

First positive data in the IMPACT trial

17. January 2022



An interim analysis of IMPACT, the Imcyse clinical trial in collaboration with INNODIA, resulted in positive data! Also recruitment reached its midpoint and the study will soon be initiated in both the US and Australia.